» Articles » PMID: 36683596

The Dual Effect of 3D-Printed Biological Scaffolds Composed of Diverse Biomaterials in the Treatment of Bone Tumors

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2023 Jan 23
PMID 36683596
Authors
Affiliations
Soon will be listed here.
Abstract

Bone tumors, including primary bone tumors, invasive bone tumors, metastatic bone tumors, and others, are one of the most clinical difficulties in orthopedics. Once these tumors have grown and developed in the bone system, they will interact with osteocytes and other environmental cells in the bone system's microenvironment, leading to the eventual damage of the bone's physical structure. Surgical procedures for bone tumors may result in permanent defects. The dual-efficacy of tissue regeneration and tumor treatment has made biomaterial scaffolds frequently used in treating bone tumors. 3D printing technology, also known as additive manufacturing or rapid printing prototype, is the transformation of 3D computer models into physical models through deposition, curing, and material fusion of successive layers. Adjustable shape, porosity/pore size, and other mechanical properties are an advantage of 3D-printed objects, unlike natural and synthetic material with fixed qualities. Researchers have demonstrated the significant role of diverse 3D-printed biological scaffolds in the treatment for bone tumors and the regeneration of bone tissue, and that they enhanced various performance of the products. Based on the characteristics of bone tumors, this review synthesized the findings of current researchers on the application of various 3D-printed biological scaffolds including bioceramic scaffold, metal alloy scaffold and nano-scaffold, in bone tumors and discussed the advantages, disadvantages, and future application prospects of various types of 3D-printed biological scaffolds. Finally, the future development trend of 3D-printed biological scaffolds in bone tumor is summarized, providing a theoretical foundation and a larger outlook for the use of biological scaffolds in the treatment of patients with bone tumors.

Citing Articles

Nano-scaffold containing functional motif of stromal cell-derived factor 1 enhances neural stem cell behavior and synaptogenesis in traumatic brain injury.

Bayat Tork M, Saberifar M, Joneidi Yekta H, Hajinejad M, Ravandi H, Gorji A Sci Rep. 2025; 15(1):5811.

PMID: 39962142 PMC: 11832925. DOI: 10.1038/s41598-025-85698-5.


Osteosarcoma: A comprehensive review of model systems and experimental therapies.

Robbins G, Vue Y, Rahrmann E, Moriarity B Med Res Arch. 2025; 12(11).

PMID: 39916749 PMC: 11801376. DOI: 10.18103/mra.v12i11.6000.


3D Bioprinting in Cancer Modeling and Biomedicine: From Print Categories to Biological Applications.

Yang J, Wang L, Wu R, He Y, Zhao Y, Wang W ACS Omega. 2024; 9(44):44076-44100.

PMID: 39524656 PMC: 11541486. DOI: 10.1021/acsomega.4c06051.


Research trends of bone tumor treatment with 3D printing technology from 2013 to 2022: a bibliometric analysis.

Chu J, Zhang Y, Jiang Y, Wu H, Wang W, Wang M Discov Oncol. 2024; 15(1):359.

PMID: 39160379 PMC: 11333674. DOI: 10.1007/s12672-024-01207-6.

References
1.
Nikolova M, Chavali M . Recent advances in biomaterials for 3D scaffolds: A review. Bioact Mater. 2019; 4:271-292. PMC: 6829098. DOI: 10.1016/j.bioactmat.2019.10.005. View

2.
McGovern J, Griffin M, Hutmacher D . Animal models for bone tissue engineering and modelling disease. Dis Model Mech. 2018; 11(4). PMC: 5963860. DOI: 10.1242/dmm.033084. View

3.
Awad A, Fina F, Goyanes A, Gaisford S, Basit A . 3D printing: Principles and pharmaceutical applications of selective laser sintering. Int J Pharm. 2020; 586:119594. DOI: 10.1016/j.ijpharm.2020.119594. View

4.
Barabaschi G, Manoharan V, Li Q, Bertassoni L . Engineering Pre-vascularized Scaffolds for Bone Regeneration. Adv Exp Med Biol. 2015; 881:79-94. DOI: 10.1007/978-3-319-22345-2_5. View

5.
Gu B, Choi D, Park S, Kim Y, Kim C . 3D Bioprinting Technologies for Tissue Engineering Applications. Adv Exp Med Biol. 2018; 1078:15-28. DOI: 10.1007/978-981-13-0950-2_2. View